← Back to Search

High Risk Pancreatic Cystic Neoplasm for Pancreatic Cyst

N/A
Recruiting
Led By Kevin Soares, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

The purpose of this study is for researchers to find ways of detecting pancreatic ductal adenocarcinoma/PDAC early to avoid the invasive procedure of surgery. The study researchers think a combination of imaging and a series of blood tests may be an effective way to detect PDAC early. In this study, researchers will look at whether a combination of the following types of imaging with blood tests can detect PDAC in pancreatic cysts: The ImmunoPET scan (immune-positron emission tomography scan) with the imaging agent 89Zr-DFO-HuMab-5B1 The HP MRI scan (hyperpolarized pyruvate magnetic resonance imaging scan)

Eligible Conditions
  • Pancreatic Cyst

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity of ImmunoPET to identify presence or absence of adenocarcinoma

Trial Design

1Treatment groups
Experimental Treatment
Group I: High Risk Pancreatic Cystic NeoplasmExperimental Treatment3 Interventions
Participants will be diagnosed with a pancreatic cystic neoplasm deemed to be high risk and requiring surgical resection

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,933 Previous Clinical Trials
585,597 Total Patients Enrolled
1 Trials studying Pancreatic Cyst
700 Patients Enrolled for Pancreatic Cyst
Kevin Soares, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
2024. "A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06305728.
All > New York City > Philadelphia
~17 spots leftby Mar 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top